期刊文献+

维持血液透析患者肿瘤发生及其相关因素的探讨 被引量:3

Tumor occurrence and its related factors in maintenance hemodialysis patients
原文传递
导出
摘要 目的探讨维持血液透析患者肿瘤发生情况及其相关因素。方法选取北京中医院顺义医院2014-1-2017-12收治的维持性血液透析患者83例为研究对象,收集患者的一般资料及实验室检查结果,分析与恶性肿瘤相关的因素。结果83例维持性血液透析患者发生恶性肿瘤9例(10.8%),其中泌尿系统发生率最高55.6%,恶性肿瘤发生与高龄、长时间透析、低白蛋白血症相关。结论维持血液透析患者容易发生恶性肿瘤,其中以泌尿系统最常见,对于高龄、长时间透析的低蛋白血症患者需加强监测。 OBJECTIVE To explore the occurrence and related factors of tumor in patients with hemodialysis.METHODS Selection methods from January 2014 to December 2017 were treated 107 cases of patients with maintenance hemodialysis as the research object,collect the patient’s general data and laboratory test results,analysis of the factors associated with malignant tumor.RESULTS 83 patients with maintenance hemodialysis patients undergo malignant tumor 9cases(10.8%),among them the occurring rate of urinary system is up to 55.6%,malignant tumor associated with older age,dialysis for a long time,low serum albumin leels related.CONCLUSIONS It is easy to develop malignant neoplasms in patients with hemodialysis,which is the most common in the urinary system,and it needs to be monitored in patients with low protein level of advanced age and long time dialysis.
作者 刘慧洁 LIU Hui-jie(Beijing Hospital of traditional Chinese medicine,Shunyi hospital,Beijing101300,P.R.China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2018年第S2期85-85,87,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 维持性血液透析 肿瘤 泌尿系统 maintenance hemodialysis tumor urinary system
  • 相关文献

参考文献2

二级参考文献16

  • 1Jacek Rysz,Maciej Banach,Aleksandra Cialkowska-Rysz,Robert Stolarek,Marcin Barylski,Jaroslaw Drozdz,Piotr Okonski.Blood Serum Levels of IL-2, IL-6, IL-8, TNF-α and IL-1β in Patients on Maintenance Hemodialysis[J].Cellular & Molecular Immunology,2006,3(2):151-154. 被引量:14
  • 2OU JH,PAN CC,LIN JS,et al.Transitional cell carcinoma in dialysis patients[J].Eur Urol,2000,37(1):90-94.
  • 3WU CF,SHEE JJ,HO DR,et al.Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma[J].J Urol,2004,171(1):126-129.
  • 4MAISONNEUVE P,AGODOA L,GELLERT R,et al.Cancer in patients on dialysis for endstage renal disease:an international collaborative study[J].Lancet,1999,354(9173):93-99.
  • 5MATAS AJ,SIMMONS RL,KJELLSTRAND CM,et al.Increased incidence of malignancy during chronic renal failure[J].Lancet,1975,1(7912):883-886.
  • 6LIN HF,LI YH,WANG CH,et al.Increased risk of cancer in chronic dialysis patients:a populationbased cohort study in Taiwan[J].Nephrol Dial Transplant,2012,27(4):1585-1590.
  • 7ZHANG Y,ZHU C,CURADO MP,et al.Changing patterns of bladder cancer in the USA:evidence of heterogeneous disease[J].BJU Int,2012,109(1):52-56.
  • 8WU CF,PANG ST,SHEE JJ,et al.Identification of genetic alterations in upper urinary tract urothelial carcinoma in endstage renal disease patients[J].Genes Chromosomes Cancer,2010,49(10):928-934..
  • 9YOSSEPOWITCH O,SAGY I,MARGEL D,BANIEL J.Urothelial carcinoma of the bladder in patients on hemodialysis:Clinical characteristics and oncological outcomes[J].J Urol,2012,187(4):1215-1219.
  • 10TSENG SF,CHUANG YC,YANG WC.Longterm outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma[J].Int Urol Nephrol,2011,43(4):1067-1071.

共引文献5

同被引文献20

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部